Chantal Bazenet

De Crespigny Park
London, ENG, United Kingdom

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 19 publications

Corrigendum to "Understanding the role of the hematopoietic niche in Huntington's disease's phenotypic expression: In vivo evidence using a parabiosis model" [Neurobiol Dis. 2023 May;180:106091. doi:10.1016/j.nbd.2023.106091. Epub 2023 Mar 24].

Corrigendum to "Understanding the role of the hematopoietic niche in Huntington's disease's phenotypic expression: In vivo evidence using a parabiosis model" [Neurobiol Dis. 2023 May;180:106091. doi:10.1016/j.nbd.2023.106091. Epub 2023 Mar 24].

Journal: Neurobiology of disease

Published: September 18, 2023

Understanding the role of the hematopoietic niche in Huntington's disease's phenotypic expression: in vivo evidence using a parabiosis model.

Understanding the role of the hematopoietic niche in Huntington's disease's phenotypic expression: in vivo evidence using a parabiosis model.

Journal: Neurobiology of disease

Published: January 19, 2023

Correction: Shedding a new light on Huntington's disease: how blood can both propagate and ameliorate disease pathology.

Correction: Shedding a new light on Huntington's disease: how blood can both propagate and ameliorate disease pathology.

Journal: Molecular psychiatry

Published: July 26, 2020

Shedding a new light on Huntington's disease: how blood can both propagate and ameliorate disease pathology.

Shedding a new light on Huntington's disease: how blood can both propagate and ameliorate disease pathology.

Journal: Molecular psychiatry

Published: January 07, 2020

Huntingtin Aggregates and Mitochondrial Pathology in Skeletal Muscle but not Heart of Late-Stage R6/2 Mice.

Huntingtin Aggregates and Mitochondrial Pathology in Skeletal Muscle but not Heart of Late-Stage R6/2 Mice.

Journal: Journal of Huntington's disease

Published: March 01, 2019

Plasma Protein Biomarkers for the Prediction of CSF Amyloid and Tau and [18F]-Flutemetamol PET Scan Result.

Plasma Protein Biomarkers for the Prediction of CSF Amyloid and Tau and [18F]-Flutemetamol PET Scan Result.

Journal: Frontiers in aging neuroscience

Published: July 10, 2018

Blood-Based Biomarker Candidates of Cerebral Amyloid Using PiB PET in Non-Demented Elderly.

Blood-Based Biomarker Candidates of Cerebral Amyloid Using PiB PET in Non-Demented Elderly.

Journal: Journal of Alzheimer's disease : JAD

Published: April 01, 2016

Correction to "Glycosylation of Human Plasma Clusterin Yields a Novel Candidate Biomarker of Alzheimer's Disease".

Correction to "Glycosylation of Human Plasma Clusterin Yields a Novel Candidate Biomarker of Alzheimer's Disease".

Journal: Journal of proteome research

Published: February 02, 2016

Glycosylation of Human Plasma Clusterin Yields a Novel Candidate Biomarker of Alzheimer's Disease.

Glycosylation of Human Plasma Clusterin Yields a Novel Candidate Biomarker of Alzheimer's Disease.

Journal: Journal of proteome research

Published: October 22, 2015

Blood metabolite markers of neocortical amyloid-β burden: discovery and enrichment using candidate proteins.

Blood metabolite markers of neocortical amyloid-β burden: discovery and enrichment using candidate proteins.

Journal: Translational psychiatry

Published: August 18, 2015

Blood Protein Markers of Neocortical Amyloid-β Burden: A Candidate Study Using SOMAscan Technology.

Blood Protein Markers of Neocortical Amyloid-β Burden: A Candidate Study Using SOMAscan Technology.

Journal: Journal of Alzheimer's disease : JAD

Published: April 18, 2015

Plasma protein biomarkers of Alzheimer's disease endophenotypes in asymptomatic older twins: early cognitive decline and regional brain volumes.

Plasma protein biomarkers of Alzheimer's disease endophenotypes in asymptomatic older twins: early cognitive decline and regional brain volumes.

Journal: Translational psychiatry

Published: March 02, 2015

Showing 1-12 of 19

Last Updated: 09/26/2026